![]() |
![]() |
![]() |
||
|
|
Our Track Record |
|||
|
What have we been up to lately? Ailm Consulting's performance can perhaps best be assessed through our actual record. Here is a sample of some achievements:
Client: Cancer treatments discovery company Problem: Unprofitable acquisition Solution: General management for an unprofitable R & D-based immunodiagnostics manufacturer on behalf of its acquirer, a publicly-traded biopharmaceutical research company. Focused marketing efforts on the most newsworthy single product in the portfolio (a novel and high-profile diagnostic to detect breast cancer early), building both a media and government cheering section in North America. The led to US FDA approval for both factory and product and to an innovative 3-sided deal with a major US biopharmaceutical firm allied with a major distributor to actively promote the test to oncologists, the first time this had been done. Results: The business made money after an unprofitable thirteen year history and proved to be an attractive acquisition candidate for an offshore clinical diagnostics marketer. Case History 2 Client: Analytical Instruments maker Problem: Strategy for a new opportunity Solution: Ailm Consulting was contracted to provide project leadership to a "skunk works" team in a global analytical instrument partnership. The project objective was for the business to capitalize on opportunities presented by rising public interest in lifelong health management. Ailm Consulting spent 30 months building key alliances with "brand-name" institutions throughout Europe and North America. This attracted the interest of the largest division of the R & D partner, who incorporated the business into their operations. Results: This project did much to define the business space now represented by the discipline of metabolomics, and positioned the parent company to take advantage of new understandings in biochemical and phenotypic profiling to create other spin-off ventures. Client: Publicly-traded technology transfer corporation Problem: Corporate partnering and additional venture financing for lead portfolio firm Solution: A senior Ailm Consulting member was engaged as Chief Executive Officer of a Guelph University-derived cutting edge crossover company by the founding investor and Board of Directors. The project involved the application of advanced computational algorithms developed for horticultural and agricultural purposes to a novel field for this client - pharmaceutical drug discovery. We negotiated a key alliance with a leading US pharmaceutical services company to develop a brand new intellectual property portfolio in computer-generated screening of clinical candidate molecules. This alliance attracted a leading publicly-traded genomics firm to merge to create a drug discovery platform through a secondary public offering of $15m. Results: Enabled a new and much
broader scale of corporate growth and development, and provided the
founders with significant liquidity. Client: Technology management company Problem: Executive leadership and management counsel Solution: Ailm Consulting provided leadership and guidance for a period of 18 months to a promising portfolio company in Kingston on behalf of its founders, a leading technology management firm and five tenured Queen’s University professors. During this time, we hired a virtual management team, formed a new Board of Directors and engaged key senior counsel. This enabled us to define and further develop the most promising and fundable compound class in the Company's portfolio. Ailm Consulting negotiated $4 million in venture capital financing, which enabled the Company to relocate to a more strategic site and recruit a new permanent staff complement. Results: Ailm Consulting successfully facilitated and managed the development of a viable business model so that the value of the asset could be more fully realized for the founders and the company’s future assured. Case History 5 Client: Family-owned coatings manufacturer Problem: Succession planning Solution: Ailm was engaged by a small R & D-based paint and adhesives manufacturer in Oakville with an aging founder and no succession strategy to lead it through a difficult period typical of many family firms. We provided executive management as the founder disengaged, coached the family management team in business process to assist them in taking over day-to-day paint operations from their father, and facilitated the full sale of the adhesives business to a younger partner. Results: A seriously dysfunctional operating environment developing in a mature family business was effectively defused and reorganized to enable proper transition from one generation to the next.
Client: Medical device developer Problem: Revenue and credibility Solution: Hired by a wealthy US founding family and Board to provide executive leadership to the major division of a publicly-traded US-based company operating internationally out of premises in Montreal and New Jersey. There were several complex aspects to the project including the technology being novel biopolymers used for therapeutic applications (virgin territory for regulatory agencies); the company manufacturing in Quebec with French-language employees through a joint venture with a local venture capital fund with social goals; marketing approvals being in place offshore several years before USA marketing was anticipated; and the stock having no proper analyst following. A large-value strategic partnering deal for the flagship product was inked with a ‘Big Pharma’ multinational in several major European countries and U.S.A. We successfully launched in Sweden and turned a profit in Canada, the initial marketplace, through ground-breaking direct to patient promotion and a co-marketing deal with another multinational. E.C. and U.S. export approvals for manufacturing plant and a CE Mark for marketing in Europe were facilitated. Results: With analyst and investor presentations, these actions supported a threefold improvement in stock price, which lead to the eventual sale of the firm to a multinational and wealthy retirement of the founding family
|
||||
|
|
Copyright © 2004. All rights reserved. |
|
||
|
|
|
|
|
|